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ABSTRACT
Plasmacytomas of the testis are extremely rare tumours, especially when occurring in the absence 
of a previous or concurrent diagnosis of multiple myeloma. We report a new case of solitary 
testicular plasmacytoma, with immunohistochemical studies showing monoclonal cytoplasmic 
production of IgG lambda light chains, in a 51-year-old man who had no evidence of multiple 
myeloma 3 years after the orchiectomy. 
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INTRODUCTION                                                    
The testis is an uncommon extramedullary 
site for plasmacytoma. Even more unusual 
are solitary testicular plasmacytomas, 
manifesting in the absence of a previous or 
concurrent diagnosis of multiple myeloma. 
To the best of our knowledge, 22 similar 
cases have been previously reported in 
the literature, of which 12 did not develop 
multiple myeloma during variable periods of 
follow-up (Table 1).
We report here the case of a solitary testic-
ular plasmacytoma, with immunohistochemi-
cal studies showing monoclonal cytoplasmic 
production of IgG lambda light chains, in 
a 51-year-old man who had no evidence of 
multiple myeloma 3 years after the orchiec-
tomy. This is the second case reported in the 
literature with IgG lambda in immunochemi-
cal studies. The case is discussed together 
with the data collected by a Medline-based 
review of the literature.
CASE REPORT                                      
A 51-year-old man presented with a 
2-month history of painless right testicular 
enlargement. He had no past history of mul-
tiple myeloma or other lymphoproliferative 
disorder.
On examination, the right testis was hard 
and regularly enlarged. The tumor did not 
involve the epididymis or spermatic cord. 
Otherwise, the physical examination was 
unremarkable with no tenderness or inguinal 
lymphadenopathy.
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lower pole of the testis. It extended 
to, but did not appear to penetrate the 
tunica albuginea. Histologic examination 
showed sheets of slightly atypical plasma 
cells, some with multiple nuclei (Fig. 1). 
Immunohistochemical study of the tumor 
specimens revealed cytoplasmic positivity 
for IgG and its lambda light chain. IgM, IgA 
and kappa chains were not identified, thus, 
confirming the monoclonal nature of this 
neoplasm (Fig .2).
Due to these findings, the patient 
underwent a diagnostic workup in search 
of systemic plasma cell disease. Serum 
protein electrophoresis performed 2 
Ultrasonography showed a large, 
heterogeneous right testis with a hypoechoic 
and hypervascular lesion in the lower 
pole, suggestive of testicular tumor. 
Routine laboratory test results as well as 
serum testicular tumor markers including 
human chorionic gonadotropin (HCG) and 
α-foetoprotein (αFP) were normal.
Diagnosis was right testicular 
tumor and right radical orchiectomy 
was performed without complications. 
Macroscopically, the testis measured 8.5 
x 5 x 4 cm. On cut section, there was a 
focally well-circumscribed grey-tan firm 
tumor measuring 5 x 4 x 4 cm in the 
Table 1: Immature plasma cells with eccentric nuclei and prominent nucleoli. H&E, reduced from x 100.





1 Anderson12/1949 R 72 NA Or + RT NA NA
2 Eckert and Smith13/1963 R 50 NA Or + RT Yes / 1 y DD / 1 y
3 Gowing7/1964 R 50 NA Or Yes / 3 y DD / 3 y
4            “ B 50 NA Or Yes / 1 y DD / 1 y
5 Levin and Mostofi14/1970 B 46 NA Or Yes DD / 26 m
6            “ R 48 NA Or No AND / 2 m
7 Oldham and Polmar15/1973 L 44 Ig D λ Or No AND / 3 y
8 Kaneshige et al16/1980 L 73 Ig G κ Or No AND / 1 y
9 Taylor et al17/1986 L 55 IgA κ Or Yes / 6 y DD / 7 y
10 Terzian et al1/1987 R 52 IgA λ Or No AND / 1 y
11 Oppenheim et al5/1991 L 71 IgA λ Or No AND / 9 m
12 Croft8/1992 R 74 λ Chain Or No AND / 1 y
13 White and Chan2/1995 L 72 IgG κ Or No AND / 41 m
14 Iizumi et al9/1995 L 83 IgG λ Or No AND / 14 m
15 Fischer et al [18]/1996 L 54 IgA λ Or No AND / 1 y
16 Ferry et al19/1997 NA 89 NA Or Yes / 18 m DD / 3 y
17 Reddi et al20/1998 R 62 λ Chain Or No AND / 16 m
18 Pham et al21/2000 B 48 Λ Chain Or NA NA
19 Suzuki et al10/2001 R 86 IgG Or No AND / 9 m
20 Hou et al22/2003 R 34 Κ Chain Or + CT Yes / 3 y AD / 7 y
21 Walker et al23/2005 L 67 NA Or NA NA
22 Chelly et al24/2007 R 65 Κ Chain OR + CT No AND / 6 m
23 Our case/2009 R 51 IgG λ Or + RT No AND / 30 m
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weeks postoperatively revealed a discreet 
gamma spike, which was characterized 
by immunoelectrophoresis as an IgG 
lambda protein. After one month, serum 
electrophoresis and immunoelectrophoresis 
were normal. Myelography and bone marrow 
biopsy showed no lesions suggestive of 
multiple myeloma. Computed tomography 
of the abdomen revealed no abnormal masses 
or lymphadenopathy. Serum and urinary 
proteins, creatinine and calcium were within 
the reference range.
The patient underwent external beam 
radiotherapy to the right scrotum. He tolerated 
this procedure without complications and 
remained well without any evidence of 
recurrence 3 years after the orchiectomy.
DISCUSSION                                                             
Extramedullary plasmacytoma refers to 
plasma cell tumors arising in any organ outside 
the bone marrow. They most commonly 
involve the upper respiratory tract, lymph 
nodes, oral cavity and gastrointestinal tract1,2. 
Cases with proven testicular involvement 
are very rare. The majority of these lesions 
occur in the setting of multiple myeloma3,4. 
In 1991, Oppenheim et al5 reported 37 
cases of testicular plasmacytoma and only 6 
developed in patients without previously or 
concurrently diagnosed multiple myeloma, 
testifying the extreme rarity of solitary 
plasmacytoma of the testis. In 1997, Castagna 
et al6 compiled 57 cases, of which only 11 
had no multiple myeloma during 2 months to 
3 years of follow-up. In 2002, Anghel et al3 
compiled 51 cases, of which 17 were solitary 
plasmacytomas and only 7 of these did not 
develop multiple myeloma during follow-up.
With a Medline based review of the 
literature we collected 22 cases of solitary 
testicular plasmacytoma (Table 1). The mean 
patient age was 60 years (range 34-89 years). 
Ten were on the right side, 8 on the left one 
and 3 were bilateral (side not available in 
one case). Only 12 cases did not progress 
to multiple myeloma during 2 to 41 months 
of follow-up. Hence it cannot be over-
emphasized that patients presenting with an 
apparently solitary testicular plasmacytoma 
either already have subclinical disseminated 
disease or will develop systemic myeloma 
if followed up for a sufficiently long time2. 
Full clinical investigation (serum protein 
electrophoresis, skeletal imaging and bone-
marrow biopsy) and long-term follow-up are 
imperative to assess the risk of developing 
generalized multiple myeloma in patients 
with testicular solitary plasmacytoma. The 
better overall survival described for these 
patients needs to be confirmed by larger 
cohort studies2-4. Gowing7 proposed that 
the assessment of the primary or secondary 
nature of an extramedullary plasmacytoma 
must be made on the basis of retrospective 
observation for about one year during which 
time no evidence of serum immunoglobulin 
or bone abnormalities is observed. Terzian 
et al1 supported Gowing’s criteria in their 
case report of testicular plasmacytoma. Our 
case fulfils these criteria and has no history 
Fig. 2: Immunohistochemical stain demonstrates plasma cells 
strongly positive for lambda light chain. Reduced from x 100.
Fig. 1: Immature plasma cells with eccentric nuclei and 
prominent nucleoli. H&E, reduced from x 100.
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of other extramedullary plasmacytoma after 
3 years of follow-up.
The clinical presentation of testicular 
plasmacytoma may be identical to that of 
any other primary or metastatic testicular 
neoplasms4. Ultrasonography of the scrotum 
is optimal for evaluating scrotal masses, and 
some testicular tumors have a distinctive 
echo pattern. Previous reports of testicular 
plasmacytoma described a relatively non-
homogeneous or heterogeneous hypoechoic 
pattern, as in our case. However, this 
is not specific for plasmacytoma, and 
ultrasonography is unable to distinguish it 
from testicular germ cell tumors8, 9. There 
are only 2 reports where the preoperative 
diagnosis was made based on the hydrocele 
fluid cytology10, 11.  
The serum M-protein detected by 
immunoperoxidase staining in our patient, 
2 weeks after the orchiectomy, was of IgG 
lambda isotype. After one month, serum 
electrophoresis and immunoelectrophoresis 
were normal, proving that there were no 
residual plasma cells in the circulating blood. 
Most of the reported patients analysed by 
immunoperoxidase staining had IgA, only 
one case was IgG lambda, like our patient9. 
The rarity of this condition does not 
permit delineation of a precise therapeutic 
approach. Management of the 22 reported 
cases consisted of radical orchiectomy with 
subsequent surveillance in 16, radiotherapy 
in 4 and chemotherapy in 2 cases (Table 1).
The prognosis of testicular plasmacytoma 
associated with multiple myeloma is poor, 
with postoperative survival ranging from 5 
weeks to 48 months. The prognosis in the 
absence of previous or concurrent multiple 
myeloma is better, but requires strict long-
term observation4.
Conclusion: Although rare, plasmacytoma 
of the testis should be considered in the dif-
ferential diagnosis of a testicular mass, par-
ticularly in a patient with known myeloma. 
Given the strong association between testicu-
lar plasmacytoma and multiple myeloma or 
plasmacytomas elsewhere, any patient who 
presents with testicular plasmacytoma should 
be investigated and monitored for the poten-
tial development of these entities.                         
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